SITC Cancer Immunotherapy CONNECT

sitc_log_color.png

The Society for Immunotherapy of Cancer statement on access to IL-6-targeting therapies for COVID-19 

Read the statement


WINLI

WIN Leadership Institute

The Women in Cancer Immunotherapy Network (WIN) Leadership Institute returns this summer and will grow to two programs, in Seattle (July 13–14) and Chicago (Aug. 3–4). The one-and-a-half-day programs celebrate and empower emerging women leaders in the cancer immunotherapy field. Apply for the opportunity to attend by April 6, 2020.

LEARN MORE AND APPLY

 Disis

Why I'm a SITC Member

Join Mary Disis, MD, FACP, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member


New Online Patient Course Available: Understanding Cancer Immunotherapy 
Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy

aci17-Online-clr.png

Toxicity Management Course 

A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now



sitc_log_color.png

Meet-the-Expert Webinar: CV and Cover Letter Writing: Academia vs Industry

SITC is pleased to host this free webinar on April 16, 2020, from 1–2 p.m. EDT. This one-hour webinar moderated by Ravi Patel, MD, PhD, and presented by Tahi Ahmadi, MD, PhD, and Christian Capitini, MD, will discuss CV and cover letter writing tactics from both an academia and industry perspective.

LEARN MORE AND REGISTER

sitc_log_color.png

2020 FOCIS-SITC Cancer Immunity and Immunotherapy Course

This course will review tumor immunology as the scientific foundation for the current practice of cancer immunotherapy, emphasizing fundamental principles, clinical advances, limitations and opportunities to accelerate clinical programs. This course is part of FOCIS' pre-Annual Meeting courses and will be held on June 23, 2020.

LEARN MORE AND REGISTER

Consistent with the Safer at Home Order issued by the Department of Health Services of the State of Wisconsin, all SITC Executive Office staff will be working remotely beginning March 25 and are best reached through email. General inquiries can be sent to info@sitcancer.org. Thank you for understanding.

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Purpose: Conversations directly relevant to patient care Audience: Practicing clinicians and staff, clinical investigators Suggested topics: demographics, clinical presentation, diagnostic testing, patient management issues/insights, patterns in ...

    3 people recommend this.
  • Purpose: Conversations directly relevant to research Audience: Laboratory and translational scientists Suggested topics: Data sharing, emerging literature, sample/tissue collection, model/reagent development, opportunities for collaboration, translational ...

    1 person recommends this.
  • I am posting to this board in case I can be of assistance. Some of you may know my father who brought this discussion board to my attention. My background is in plasma physics and manufacturing. You may be aware of the article: https://www.safety.duke.edu/ ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More